Merck KGaA finds consumer health buyer in P&G for €3.4bn
April 19, 2018Sales and Marketing Merck KGaA, P&G, Pfizer, biotech, drugs, pharma, pharmaceutical
Merck KGaA has successfully found a buyer for its healthcare unit, after Proctor & Gamble announced that it was prepared …
EMA initiates divorce process from the UK’s MHRA
April 19, 2018Medical Communications EMA, UK government, biotech, brexit, drugs, pharma, pharmaceutical
The first stage of separation for the EMA from the UK came with the decision to relocate its headquarters to …
Immunomedics’ whirlwind in the C-suite continues
April 18, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Immunomedics hasn’t had the most straight forward year, its $2 billion deal with Seattle Genetics was scuppered by activist investors, …
Frequency Therapeutics hires industry vet
April 18, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Frequency Therapeutics is a biotech with big ideas and it has made a big appointment to back up those ideas, …
BMS’ Opdivo+Yervoy combo secures FDA approval in kidney cancer
April 18, 2018Research and Development, Sales and Marketing BMS, Bristol Myers Swuibb, Cancer, FDA, Yervoy, carcinoma, opdivo, pharma
The FDA has announced its approval of a combination of Opdivo (nivolumab) and Yervoy (ipilimumab), both products from Bristol Myers …
EpiPen shortage hits UK and Canada hard, but not US
April 18, 2018Research and Development, Sales and Marketing Mylan, Pfizer, biotech, drugs, epipen, pharma, pharmaceutical
Manufacturing issues at the single Pfizer plant that produces the EpiPen epinephrine injector has caused serious shortages in the UK …
Amgen and Novartis’ Aimovig shines in migraine at Phase 3
April 18, 2018Research and Development Aimovig, Amgen, Novartis, migraine, pharma
Amgen has lifted the curtain on complete Phase 3 data for its calcitonin gene-related peptide receptor (CGRP) inhibitor Aimovig (erenumab) in …
Sanofi CFO set to step down this year
April 18, 2018Medical Communications, Research and Development Sanofi, biotech, cfo, drugs, pharma, pharmaceutical
After a busy start to the year, with a number of acquisitions and a few divestments, Sanofi’s Chief Financial Officer, …
All indications point to approval for cannabis-based therapy
April 17, 2018Research and Development, Sales and Marketing FDA, GW Pharma, biotech, drugs, pharma, pharmaceutical
GW Pharma are inching step by step towards a likely approval with the FDA, after it received a strong recommendation …
Novartis to invest $100m in new malaria treatments
April 17, 2018Manufacturing and Production, Research and Development Novartis, WHO, malaria, pharma
Novartis has revealed it is to invest $100 million into the research and development of new treatments for malaria over …
FDA flip-flops on Alkermes’ drug application
April 17, 2018Manufacturing and Production, Sales and Marketing Alkermes, FDA, biotech, drugs, pharma, pharmaceutical
Two weeks ago, it looked like the hopes for Alkermes’ ALKS 5461 receiving approval would rely on returning to the …
Amazon puts selling pharmaceuticals plan on back-burner
April 17, 2018Manufacturing and Production, Sales and Marketing amazon, biotech, drugs, pharma, pharmaceutical, pharmacy
Last year buzz about Amazon entering the pharmaceutical distribution market steadily grew after it obtained pharmacy licenses in a small …
Keytruda success continues, beating Opdivo in lung cancer survival
April 17, 2018Manufacturing and Production, Research and Development Cancer, MSD, NSCLC, keytruda, lung cancer, pharma
Not content with revealing two strong waves of data on its flagship immunotherapy Keytruda (pembrolizumab) over the past weeks, MSD …
Frequency Therapeutics hires industry vet
April 16, 2018Manufacturing and Production, Medical Communications Frequency Therapeutics, biotech, drugs, pharma, pharmaceutical
Frequency Therapeutics is a biotech with big ideas and it has made a big appointment to back up those ideas, …
Care packaging: Inside the Falsified Medicines Directive
April 16, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, packaging, pharma, pharmaceutical
When it comes to the pharmaceutical supply chain, patient safety has and will always be a primary concern for all …
Novartis’ Entresto helps preserve kidney function in chronic heart failure patients
April 16, 2018Research and Development, Sales and Marketing Entresto, Novartis, heart failure, pharma
Novartis has lifted the curtain on new data from a Phase 3 trial investigating the efficacy of Entresto (sacubitril/valsartan) in …
Sanofi looks to trim down with divestments
April 16, 2018Sales and Marketing Charterhouse Capital, Sanofi, Zentiva, biotech, drugs, pharma, pharmaceutical
Sanofi has begun part of a larger process of slimming down its business with the sales of 12 medicines. It …
J&J’s ketamine nasal spray for depression continues to impress
April 16, 2018Research and Development, Sales and Marketing Johnson & Johnson, Ketamine, biotech, drugs, pharma, pharmaceutical
New treatments for depression are few and far between; pharmaceutical companies have shied away from trying to develop new therapeutics …
Keytruda continues success with new Phase 3 data in adjuvant melanoma
April 16, 2018Research and Development, Sales and Marketing Cancer, MSD, keytruda, melanoma, pharma, skinc cancer
MSD has revealed new efficacy data for Keytruda (permbrolizumab) as an adjuvant therapy in the treatment of resected, high-risk stage …
Shire jettisons oncology unit for $2.4bn, unbalancing Takeda deal
April 16, 2018Sales and Marketing Servier, Shire, Takeda, biotech, drugs, oncology, pharma, pharmaceutical
Shire has announced that it has entered a definitive agreement for French drugmaker Servier to take on its oncology business. …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
